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High-speed science

Tens of thousands of simultaneous experiments on
gene function? It’s all in a day’s work at the Center for
High Throughput Cell Biology, one of the first groups
to move into Yale’s West Campus.
12

o n t h e c o v e r The Center for
High Throughput Cell Biology
relies on complex robots, laser
microscopes, and vast computing
power to determine the functions of genes. Automated plate
handlers in the high throughput
cell biology core can batch-process
tens of thousands of cell-based
assays simultaneously, using
small interfering rnas to silence
individual genes.
t h i s pag e Vapor from a liquid
nitrogen freezer hugs the floor in
the center’s laboratory space on
Yale’s 136-acre West Campus. The
former Bayer Healthcare facility
was purchased by the university
in 2007; construction of the high
throughput facility in a portion of
the space began in July 2008.
o n t h e bac k c o v e r Jason
Ignatius is one of 16 people working
in the new center at West Campus.
Photographs by Robert Lisak
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Yale Medicine welcomes news
and commentary. Please send
letters (350 words or fewer) and
news items to Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via
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include a telephone number.
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length, style, and content.
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More premed courses
should be required

I applaud and agree with the
concepts expressed in “Reform of
Premed Education Under Way”
[Yale Medicine, Winter 2009].
My own case in point: I went
to Stanford as an undergraduate,
majoring in biology and chemistry. I took organic chemistry
as a freshman, and took two
statistics courses and a general
psychology course, all of which
should be required. I wanted to
take biochemistry, but was not
allowed to, since I was a premedical student and would have the
same course in medical school.
I took virtually every other chemistry course offered, including
the second-year/graduate biochemistry courses—17 chemistry
courses in all.
I would wish to require the
following courses or the equivalent knowledge for premedical
students, in addition to the
liberal arts components: general
statistics, biochemistry, and
psychology. My own experience
of 40 years in practice has made
me aware of the need to understand business principles and
such diverse topics as cultural
and religious viewpoints toward
health. I presume that computer
literacy is a given (I typed my
m.d. thesis in 1960 on a portable
typewriter over and over until
I got it right).

As the article by Jennifer
Kaylin suggests, it would be
wonderful if there were some
preparatory coursework for
beginning medical students
covering the wide scope of worldviews and personal interactions
needed by caring and capable
physicians. As an oncologist, I
have developed productive and
useful ways of dealing with
terminal illness that are seldom
shared with health care professionals. As Averill Liebow, m.d.,
told us in 1958, “You are students
of medicine, not schoolboys.”
Malin Dollinger, m.d. ’60
Palos Verdes, Calif.

Propaganda and the law of
unintended consequences

I am sorry I cannot be in New
Haven to see the exhibit of antiVD posters used by the armed
forces in World War II. It brings
back some poignant memories
[“Cautionary Tales for WWII GIs,”
Yale Medicine, Spring 2009].
I served in 1946 as radiologist
to the 155th Station Hospital in
Yokohama, Japan, also serving
as pharmacy officer along with
responsibility for two VD wards
and VD education for our own
hospital detachment. In the latter capacity I was required to
give a series of lectures and to
use posters, and more importantly, a series of excellent movies with story lines regarding the
dangers of unsafe sex.
The Army was segregated in
those days, and we had different movies for white and black
soldiers. The femme fatale in
the black movie was one of the
most beautiful and provocative
females I had ever seen. I was surprised when I received requests
from our white GIs to show the
black movie rather than the
other. During this period I was

informed by 8th Army HQ that
the VD rate in the hospital was
starting to rise.
It was suggested by an old
sergeant that I try showing the
movies at the beginning of the
day rather than just before the
end. I was too inexperienced
to realize that when the boys
watched the temptress at work
their hormone titers rose to
astronomical heights and they
immediately sought out the
nearest brothel. When the film
was shown early, its effects
had a whole day to wear off.
Although the new timing was
not a popular move, the VD
rate did drop to more manageable levels.
So while the propaganda
might have had some positive
results, it fell victim to the Law
of Unintended Consequences.
This was one of the best lessons I took home from my military career.
Raymond A. Gagliardi, m.d. ’45
Boca Raton, Fla.
correc tion
A photograph that appeared
in “200 Years of Medicine at
Yale,” [Yale Medicine, Spring
2009, page 20] was incorrectly
credited. The photograph is
part of the A.C. Gilbert Papers,
Manuscripts and Archives,
Sterling Memorial Library.

starting point
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A survey, a redesign, and a more frugal approach
Our thanks go to all of you who participated in our readership survey, not only for taking the time to reply, but also for
the enthusiastic support you have shown for Yale Medicine.
Online Extra
Most of you like what we’re doing, but you also gave us ideas
This new icon will alert you to
about how to do better. More than two-thirds of you ranked
online-only content that can be
found at yalemedicine.yale.edu.
Yale Medicine “above average” or “among the best” alumni
magazines you read, and almost 60 percent of you feel more
engaged with the School of Medicine after reading Yale
Medicine. You liked our mix of articles, but about half of you asked for more in-depth articles
about medicine and science, and many of you asked for more news of alumni and faculty.
We will be thinking about your ideas, suggestions, and responses as we begin our redesign
of Yale Medicine. The survey was the necessary first step prior to redesigning—we wanted to
know what you, our readers, think about the magazine. For more on the survey, visit yalemedicine.yale.edu/readersurvey.
You will have noticed by now that the issue you hold in your hands is thinner than usual.
The current economy has forced us to cut back, so this issue has just 32 pages, not the usual 48.
To continue providing you with news of the School of Medicine, we’ve moved some of our content to the Web. Throughout the magazine you’ll see references and links to online-only content.
We hope that you continue to enjoy Yale Medicine and that it continues to keep you
in touch with friends, classmates, teachers, mentors, and others who made your time at the
school so meaningful.
John Curtis
Managing Editor
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chronicle news from cedar street

Officials outline plans to
reconfigure Route 34
Over the next decade the “highway to
nowhere” will vanish and be replaced
by new stores, offices, and homes.
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In the 1950s city officials believed that
New Haven needed a highway link
to the towns of the Lower Naugatuck
Valley. The Oak Street Connector, a freeway extending from I-95 northwest, and
also known as Route 34, was thought to
be the answer—but the project was an
undisputed failure. To clear the way for
a never-completed segment of highway
that severed Yale’s medical campus and
the nearby Hill neighborhood from the
downtown, 881 families were displaced
and 350 buildings razed.
Now, more than 50 years after it was
built, New Haven Mayor John DeStefano
Jr. has proposed a plan to remove the connector, restore the street grid, and reknit
the city’s fabric.
The plan, which DeStefano announced at an April 20 press conference,

would nearly double the size of the city’s
central business district; create 4.5 million square feet of new commercial,
institutional, retail, and residential space;
produce 12,000 permanent jobs; and
generate more than $100 million annually in tax revenue.
A joint effort of the city, Yale-New
Haven Hospital, the School of Medicine, and the Economic Development
Corporation of New Haven, the plan
is by all measures ambitious. A $5 million federal grant secured by U.S.
Representative Rosa DeLauro has
funded the project so far. The cost of
the plan’s infrastructure, estimated at
$45 million, will be financed through
federal, state, and private funding.
Engineering work for this phase of
the project has already begun, but it is
expected to take years to complete.
A private-sector project will
jump-start the initiative. Winstanley
Enterprises, a property development
firm based in Concord, Mass., is ready to
break ground on a 300,000-square-foot
office and laboratory “sister building”

j enn if er k ay l in
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to 300 George Street between the Air
Rights Garage and College Street in the
Route 34 right-of-way as soon as the
state land and air rights are transferred.
Developer Carter Winstanley, owner of
300 George, envisions closing Route
34’s Exit 3, with several lanes of traffic
rerouted. An existing entrance to the Air
Rights Garage would remain.
“We are just ecstatic with the vision
that the downtown will extend to the
medical center and that we will be a part
of it,” said Dean Robert J. Alpern, m.d.,
Ensign Professor of Medicine. Alpern
said the plan addresses two important
issues: the medical school’s disconnection from “such a vibrant downtown”
and its ability to grow. The only limitation on growth in research and clinical
care is space, he said.
“We’ve been somewhat landlocked.
But now, with plans for the conversion
of the downtown, this will create opportunities for a lot of new research buildings,” Alpern said.
The plan is “going to be a positive
circumstance for the university,” said
Bruce D. Alexander, j.d., Yale’s vice president for New Haven and state affairs and
campus development. “We’ve been working hard whenever we had the opportunity to reconnect the central campus and
the medical campus. This will be a
very significant step forward.”
DeStefano said the plan is meant to
“create a footprint for what happens to
New Haven over the next 15 years.”
—Charles Gershman
U.S. Rep. Rosa DeLauro and Dean Robert Alpern
shared a laugh at a press conference on April 20
to announce the city’s plans to remake the Route
34 corridor that separates the medical campus
from downtown New Haven.
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A new ARRA for science as
stimulus package boosts NIH
grants around the country
In his inaugural address in January,
President Barack Obama pledged to
“restore science to its rightful place”
and “not only to create jobs, but to lay
a new foundation for growth.” These
goals are intertwined in a $10 billion
allocation to the National Institutes of
Health (NIH) in the economic stimulus
package approved by Congress, officially
known as the American Recovery and
Reinvestment Act of 2009 (ARRA).
The package comes as welcome relief
to biomedical scientists at the School
of Medicine and elsewhere who have
endured years of flat NIH budgets that
result in de facto cuts after adjusting
for inflation.
The ARRA moneys provided to NIH
for “extramural” distribution include
$8.2 billion for research grants, $1 billion
to support construction and renovation
at NIH-funded research institutions,
and $300 million for the purchase of
scientific equipment. An additional
$500 million will support improvements and construction at NIH’s own
research facilities.
According to Carolyn W. Slayman,
PH.D., deputy dean for academic and
scientific affairs, as of June 1 Yale
scientists had completed more than
650 ARRA grant applications requesting
nearly $387 million in support. Those
grants are in addition to typical nih
awards, which last fiscal year totaled
$350 million.
More than 250 of the ARRA applications, totaling almost a quarter billion
dollars, were made under two new NIH
grant initiatives. Challenge Grants, which

will account for at least $200 million of
the stimulus funding, will provide up to
$500,000 per year for two years, and are
aimed at what NIH terms “priority areas
of research,” such as HIV therapy, pain
management, and health disparities.
Another $200 million has been assigned
to Grand Opportunities, or “GO,” grants,
which are targeted at “high-impact, welldefined, large-scale” research projects in
such areas as nanotechnology, genomics,
and Alzheimer disease.
In addition to providing jobs for
postdocs, lab techs, administrators,
and other Yale staff members, Slayman
says, the ARRA grants will also indirectly, but significantly, stimulate the
economy by providing revenue and jobs
to equipment vendors and manufacturers, and to construction firms. Given
the high historical percentage of Yale
grant applications funded by the NIH,
Slayman hopes that a “tsunami” of
ARRA funds will begin arriving on
campus this fall.
—Peter Farley

New Haven is the first U.S. city to participate
in Community Interventions for Health
(cih), an international project to address
chronic disease.
Working with Yale’s Community Alliance
for Research and Engagement (care), cih
will study the effectiveness of community
interventions in reducing the prevalence of
chronic diseases. In New Haven, high rates
of obesity put children and minority groups
at elevated risk for heart disease, type 2
diabetes, and cancer.
cih, which works with communities to
improve health, is spearheaded globally
by the nonprofit Oxford Health Alliance and
locally by care, which is part of the Yale
Center for Clinical Investigation.
“We hope that innovative research conducted at Yale can be translated into vital
policies and programs to prevent disease and
promote the health of our citizens right here in
New Haven,” said Jeannette R. Ickovics, ph.d.,
professor of epidemiology and public health,
professor of psychology, and director of care.
—John Curtis
E M E RG E N C Y M E D I C I N E A D E PA R TM E N T

The Yale Corporation granted departmental
status in June to the Section of Emergency
Medicine, which had been part of the Department of Surgery since 1991. Gail D’Onofrio,
m.d., the current section chief, was named
chair of the new department.
A faculty committee recommended unanimously last fall that the section, which met
standards for academic and programmatic
importance, was ready to be elevated to
departmental status. Emergency medicine
has emerged as a distinct discipline during
the past two decades, and 83 percent of all
emergency medicine programs nationally are
located within independent departments.
Emergency medicine is now the 28th
academic department at the school. Since its
creation as a section, it has grown from five to
33 faculty members, who have responsibility
for 72,500 patient visits per year at Yale-New
Haven Hospital and 21,600 visits annually at
the Yale-New Haven Shoreline Medical Center
in Guilford.
—J.C.
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Sight restored with
artificial cornea
When natural transplants fail,
ophthalmologists turn to corneas
made from polymers.

j immy k . l ee ( 2 )

yale medicine autumn 2009

Sixteen years ago, when Awilda Irizarry
was 33, glaucoma was diagnosed in her
right eye. Over the years, her vision
grew increasingly blurry and the pain
became agonizing. Her doctor prescribed eyedrops to reduce pressure on
her optic nerve; finally, however, the
pain was so unbearable that Irizarry
had her eye removed.
The pain on the right side was
relieved, but Irizarry began to feel pain
and lose peripheral vision in her left eye.
She had four surgeries, including two

Ophthalmologist Jimmy Lee is one of a handful
of surgeons in the country who perform artificial
cornea transplants. These images show a patient’s cornea before (top) and after the surgery.

donor cornea transplants, but still her
vision dimmed and the pain worsened.
“She doesn’t like people to help her
much,” said Irizarry’s daughter, Maggie
Morales. “She loves being independent,
but she was frustrated losing her vision
little by little. It got to the point where
she was basically blind.”
Last August, just as Irizarry’s doctors
were running out of options, Jimmy K.
Lee, m.d., joined Yale as the new director of the cornea and refractive surgery
sections at the Yale Eye Center. Lee, who
had just completed a fellowship at the
Wilmer Eye Institute at Johns Hopkins
Hospital in Baltimore, came with a clinical interest in corneal transplantation,
including artificial corneas. After hearing Irizarry’s case history, Lee thought
Irizarry would be an ideal candidate
for an artificial cornea transplant. “The
main indication for an artificial cornea
is when patients have had multiple
failed natural cornea transplants,” Lee
said. “The immune rejection rate is
much lower because the center is an
artificial implant.”
The first artificial cornea implant
was performed less than 20 years ago,
after the device was approved for use
in the United States in 1992. “It was
uncomfortable for the patient, and there
were complications,” said Lee, one of a
handful of surgeons in the country who
perform artificial cornea transplants.
The model Lee uses is the Boston K-Pro
(also known as the Dohlman-Doane)
developed at Harvard and Massachusetts
Eye and Ear Infirmary in the 1960s by
Claes H. Dohlman, m.d., ph.d., considered the founder of modern corneal
science. The K-Pro is made of a transparent polymer that offers a visual
field almost as wide as that of a normal

cornea—the transparent part of the eye
that covers the iris, pupil, and anterior
chamber and contributes to the eye’s
focusing power. A donor cornea is used
as a “peripheral skirt” to provide tissue
into which the prosthetic implant can
incorporate itself.
The surgery takes about two hours,
and the bandages are removed the next
day. Patients are treated with steroids
and antibiotics and usually recover
fully in about a year. Glasses or contact lenses are typically prescribed to
enhance sight restoration.
It’s always an emotional moment
when the bandages come off and a
patient can see again, said Lee, who performs about two artificial cornea transplants per month. “These are patients
who at best could only see light. After
the surgery they can dress themselves,
cook and watch TV again. There aren’t
many scenarios in medicine where
there’s such a dramatic change.”
Morales said when Lee removed the
bandage from her mother’s eye, “she was
laughing and crying at the same time”
because she could see her children and
grandchildren. “It’s better in every way,”
Morales said. “Now she can see us.”
—Jennifer Kaylin
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During the past 10 years researchers
have puzzled over how best to deliver
small interfering rna (sirna) molecules,
whose therapeutic value lies in their ability to shut down genes in higher organisms and in pathogens that may cause
sexually transmitted infections (stis).
Lipid-based formulations, the most
widely used sirna delivery vehicles, suffer from certain limitations. In particular, they are unable to provide sustained
release of sirnas that may be required
for many applications, and they may be
toxic to target tissues.
Now, as reported in Nature Materials
in May, Yale scientists have found a safe
and effective way of administering sirna
molecules. “We wanted to develop a new
strategy of delivering sirnas with an
fda-approved material,” said lead author
Kim Woodrow, ph.d., a postdoctoral fellow working with W. Mark Saltzman,
ph.d., the Goizueta Foundation Professor
of Biomedical Engineering and Chemical
Engineering.
For this proof-of-principle work, the
researchers designed sirnas to target
a gene expressed widely in the lining
of the female mouse reproductive tract.
Saltzman and Woodrow used densely
loaded nanoparticles made of plga, an
fda-approved biodegradable polymer,
to create a stable time-release vehicle for
delivering sirnas to mucosal tissue.
To convert an fda-approved material
into an sirna delivery system, the
particles needed to be small enough to
penetrate tissue barriers and be taken
up by cells. These nano sized particles
also required stable incorporation of

k im w o o d r o w

Nanoparticles loaded with
siRNAs are new vehicle for
silencing genes in pathogens

To deliver small interfering rnas that can silence
genes, researchers turned to nanoparticles made
of a biodegradable polymer. The nanoparticles
were distributed throughout female reproductive tissue in mice and resulted in gene silencing
for up to 14 days.

large quantities of sirna. Saltzman and
Woodrow demonstrated that their sirna
nanoparticles were distributed and retained throughout the female reproductive
tissue. They also showed that delivery of
sirna by plga nanoparticles resulted
in sustained gene silencing in the tissue
for up to 14 days.
“Before human clinical testing can
begin, our next step in research will be
to test this approach directly in disease
models—for example in the hiv-model
mice that have an immune system
genetically identical to that of humans,”
said senior author Saltzman.
This approach may lead to antimicrobial treatments that patients can apply
themselves. “It is safe and effective, and
much easier than getting an injection of
vaccine,” Woodrow said.
—Janet Emanuel

The state of Connecticut in April awarded close
to $4 million to Yale scientists to study ways
in which human embryonic stem cells can
be used to treat such ailments as spinal cord
injuries, cancer, and mental retardation. The
grants were made by the Connecticut Stem Cell
Research Advisory Committee, formed in 2005
when the state allocated $100 million over 10
years to promote such research. Connecticut
was the third state to pass legislation allocating
funds for the study of embryonic stem cells.
Five Yale researchers received grants
worth a total of $2.5 million, and seven others
received seed grants worth a total of $1.4 million. This latest round of funding will support
such research projects as remyelination of
nonhuman-primate spinal cords and the use
of transposons—sequences of dna that can
change position within the genome of a single
cell—for genetic manipulation of human
embryonic stem cells.
—John Curtis
M A R K E R S for P R O STAT E C A N C E R

Scientists at Yale and the VA Connecticut
Healthcare System in West Haven have
reported a link between molecular markers
and higher death rates from prostate cancer.
The paper appears in the May 5 issue of the
Annals of Internal Medicine.
Amidst an ongoing debate in the medical community over whether screening and
early diagnosis of prostate cancer save lives,
or whether the aggressiveness of the tumor
is more relevant in determining survival,
the scientists studied tissue from biopsies of
more than 1,000 veterans diagnosed with
prostate cancer between 1991 and 1995. They
found that abnormal expression of the Bcl-2
gene or of the p53 tumor suppressor gene
increased the likelihood of patients’ death
from prostate cancer.
“Our results expand the current ability
of clinicians to evaluate the aggressiveness
of prostate cancer,” said lead author John
Concato, m.d., m.p.h., professor of medicine.
“Future research can help to define specific biologic mechanisms and develop new therapies.”
—J.C.
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A questionable tradition
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The dissection photo, now taboo, and its societal implications are explored in a history of the genre.
During the five decades from the Gilded Age to the Great
Depression, American medical students created a distinctive
genre of photograph: the group portrait with cadaver. First
popularized in the 1880s, these tableaux commemorate the
experience of dissection—what co-author John Harley Warner
calls “a harrowing ritual of initiation.” His new book contains
roughly 200 such photographs.
Warner, chair of the Section
of the History of Medicine at the
School of Medicine, describes dissection as central to early medical
education, and yet “transgressive,
practiced on the social, legal, and
moral margins.” He analyzes the
photographs to explore societal
ambivalence about dissection,
Disssection: Photographs
gender roles, race, class, and the
of a Rite of Passage
iconography of the white coat.
in American Medicine
Warner collaborated with the chief
1880–1930
curator at the Dittrick Medical
by John Harley Warner,
History Center at Case Western
ph.d., Avalon Professor of
Reserve University to collect the
the History of Medicine;
and James M. Edmonson
portraits. These photographs
(Blast Books)
proliferated during an era when
dissection was performed on paupers, executed criminals, and corpses “resurrected” from graveyards—bodies that were disproportionately black. Some photos
convey morbid humor, including pipe-smoking skeletons and
propped-up cadavers seemingly dissecting a medical student.
Warner argues that the photographs express a violent
impulse in early 20th-century society, with such captions as,
“He lived for others. He was killed for US.” By the mid-20th
century, bodies used for dissection were increasingly donated
to medical schools rather than stolen, and the dissection
photograph became taboo. Today, as Warner notes, even the
act of dissection is in question: computer simulations may
render the gross anatomy lab obsolete.
–Cathy Shufro

Genetic Diseases of the Kidney
edited by Richard P. Lifton, m.d.,
ph.d., Chair and Sterling Professor of Genetics and professor of
medicine, Stefan Somlo, m.d.; the
C.N.H. Long Professor of Medicine
and professor of genetics; Gerhard
Giebisch, m.d., Sterling Professor
Emeritus of Physiology; and Donald
Seldin, m.d. ’43, hs ’46 (Academic
Press) This book identifies and
analyzes genetic abnormalities
causing renal disease in humans.
Principles of Addiction
Medicine, 4th ed.
by Richard K. Ries, m.d.; Shannon
C. Miller, m.d.; David A. Fiellin,
m.d., hs ’95, associate professor
of medicine; and Richard Saitz,
m.d., m.p.h. (Lippincott Williams
& Wilkins) This book blends
scientific principles underlying addiction with practical essentials of
clinical addiction medicine to help
professionals who specialize in
addiction medicine and who treat
patients with addiction disorders.
The Soul of Medicine:
Tales From the Bedside
by Sherwin Nuland, m.d. ’55,
hs ’61 (Kaplan Publishing) This
book is a compilation of stories in
which more than a dozen specialists describe their most memorable patients. The contributors
also recount instances of fallibility
and vulnerability that prove that
doctors are human and caring.
Faith, Hope & Healing:
Inspiring Lessons Learned From
People Living With Cancer
by Bernie Siegel, m.d., hs ’61,
and Jennifer Sander (Wiley)
In this collection of first-person
accounts, Siegel brings together
almost three dozen cancer patients to share their stories and
the lessons they have learned
while living with cancer.

Surgery of the Human Cerebrum
edited by Michael L.J. Apuzzo,
m.d., hs ’67 (Lippincott Williams
& Wilkins) This book documents
advances in surgery on the human cerebrum during the past
30 years, bringing together new
and archival articles to provide
sources of information on contemporary cerebral surgery.
Handbook of Radiation
Oncology: Basic Principles and
Clinical Protocols
by Bruce G. Haffty, m.d. ’84, professor (adjunct) of therapeutic
radiology; and Lynn D. Wilson, m.d., m.p.h. ’86, professor
of therapeutic radiology and
dermatology (Jones and Bartlett
Publishers) This handbook covers
the issues most pertinent to
patients undergoing radiation
therapy, including general oncologic principles; workup, staging,
and multidisciplinary aspects of
treatment; basic principles of
physics and radiobiology; and
such specific technologies as
brachytherapy and radiosurgery.
Otolaryngology:
A Surgical Notebook
edited by K.J. Lee, m.d., associate clinical professor of surgery
(otolaryngology); and Elizabeth
H. Toh, m.d. (Thieme New York)
This handbook uses a bulletpoint format to present an
overview of the fundamental
concepts and core techniques
for basic and advanced otolaryngologic procedures.

on campus

Perez and Brady’s Principles
and Practice of Radiation
Oncology, 5th ed.
by Edward C. Halperin, m.d. ’79;
Carlos A. Perez, m.d.; Luther
W. Brady, m.d.; et al. (Wolters
Kluwer/Lippincott Williams &
Wilkins) This book provides an
understanding of radiation oncology; the physical methods of radiation application; the effects of
irradiation on normal tissues; and
site-specific applications of radiation therapy, either as a single
modality or as part of a multimodality treatment program.

adhd Comorbidities: Handbook
for adhd Complications in

Children and Adults
edited by Thomas E. Brown, m.d.,
assistant clinical professor of
psychiatry (American Psychiatric
Publishing) This book covers the
multiple ways in which adhd is
complicated by other psychiatric
and learning disorders in both
children and adults. Clinicians
will find help for patients whose
adhd appears in conjunction
with 11 other syndromes ranging
from mood disorders to developmental coordination disorder.
Laryngeal Physiology for
the Surgeon
by Clarence T. Sasaki, m.d. ’66,
hs ’73, the Charles W. Ohse
Professor of Surgery (Plural
Publishing) This book provides
an understanding of the three
principal functional priorities of
larynx protection, respiration,
and phonation and features numerous illustrations and tables.
Most chapters are preceded
by focused case presentations
introducing relevant clinical
descriptions.

Royal Maladies: Inherited
Diseases in the Royal Houses
of Europe
by Alan R. Rushton, ph.d., m.d.,
hs ’80 (Trafford Publishing)
The author provides an historical study of the effects of two
hereditary diseases, hemophilia
and porphyria, on the personal
and political lives of European
royal families.
Comprehensive Review
of Psychiatry
edited by Rajesh R. Tampi, m.d.,
associate clinical professor in the
Child Study Center; Sunanda
Muralee, m.d., clinical fellow in
the Child Study Center; Natalie
D. Weder; and Heath Penland
(Lippincott Williams & Wilkins)
This text will prepare resident
and practicing psychiatrists for
all types of standardized examinations, including the Psychiatry
Resident-In-Training Examination, the American Board of Psychiatry and Neurology (abpn)
written exam, and recertification exams. The book contains
2,000 multiple-choice questions
divided into 10 200-question
tests, each test covering all
psychiatry and neurology topics
in the abpn curriculum.
The descriptions above are based
on information from the publishers.

send notices of new books to
Cheryl Violante, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to cheryl.violante@yale.edu
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ERIC CAMPBELL

The fight against disease in the
developing world has often been
waged not by public health professionals, but by economists,
politicians, and even military
personnel, said Roger I. Glass,
m.p.h., m.d., ph.d., director of
the Fogarty International Center
at the National Institutes of
Health, during a talk at the medical school in April. Glass spoke
at the spring symposium of the
Wilbur Downs International
Health Travel Fellowship Program.
“It was Colin Powell and
Madeleine Albright saying the
health of Africa was a security
issue,” Glass said, that launched
the President’s Emergency Plan
for aids Relief (pepfar). “Global
health has changed in the last
10 years,” he said, noting the
emergence, in addition to pepfar,
of the Bill and Melinda Gates
Foundation and the Global
Alliance for Vaccines and Immunization, organizations that also
address health issues in the developing world. “Global health in
the 20th century was schools of
public health and departments
of international health at medical
schools. In the 21st century global
health is more than that. It is
engineering. It’s business and
organization of delivery of care.
It has to do with international
ethics and law. It has to do with
economics.”
—John Curtis

By the time they’ve reached their
third year of medical school,
said Eric G. Campbell, ph.d., virtually all medical students have
accepted a free meal from drug
companies. While this treat may
appear to be a small gift, it could
also be the first of many that lead
young doctors and scientists into
conflicts of interest and the erosion of trust between physicians
and the public.
“There’s a lot of eating going
on in academic medicine,” joked
Campbell, an associate professor
of medicine (health policy) at
Massachusetts General Hospital
and Harvard Medical School,
who spoke at the Perspectives on
Medicine series in March.
Relationships between
industry and academia are not
necessarily bad, Campbell said,
noting that the pharmaceutical
industry underwrites $1.5 billion
in research each year. “They have
benefits that are very important,”
he said. But industry-sponsored
junkets, along with ghostwriting,
speaking, consulting, and advisory fees can create the impression that medical findings are
“bought and paid for,” he added.
“Managing conflicts of interest is a fundamental part of
medical professionalism today,”
Campbell said. “We need to disclose these things and we need to
manage them.”
—J.C.

A new vanguard to address
global health

Ubiquitous industry ties have
risks and benefits
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The origins of Darwin’s The Origin of Species
An exhibit at the Cushing/Whitney Medical Library traces the evolution
of Charles Darwin’s theory.
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A medical student, appalled at what he
was witnessing, ran from the operating
room. He was little more than a boy,
having enrolled at the University of
Edinburgh at 16, but his revulsion at the
sight of human blood would stay with
him throughout his life. That distaste
was compounded by the horror of surgery before the advent of anesthesia. He
had to admit to his family that he could
not follow in his father’s and grandfather’s footsteps to become a physician.
But Charles Darwin made a name for
himself nevertheless.
Marking the 150th anniversary of
The Origin of Species and the 200th anniversary of its author’s birth, an exhibit in
the Cushing/Whitney Medical Library
rotunda from February to April explored
Darwin’s groundbreaking theory in the
context of the scientific and theological
beliefs of his contemporaries. From

john curtis

med i c a l h i s t o r i c a l l ib r a r y

By Colleen Shaddox

Natural Theology to Natural Selection:
Celebrating the Darwin Bicentenary made
use of the Historical Library’s own assets,
including a first printing of the first edition of The Origin of Species from Harvey
Cushing’s collection. Toby Appel, ph.d.,
the John R. Bumstead Librarian for
Medical History, curated the exhibit.
The exhibition opened with 17thcentury texts that sought to reconcile
scientific discoveries with Christian
beliefs. John Ray’s Wisdom of God
Manifested in the Works of Creation is
an early example of “natural theology,”
a blending of religion and science that
still had adherents when Darwin set sail
for South America in 1831. Also in the
exhibit is Zoonomia, a medical textbook
by Erasmus Darwin, grandfather to the
naturalist. Erasmus Darwin argued
that organisms inherited useful characteristics, leading to the development

of higher animals. Though muddled
with notions about spontaneous generation and not nearly as well supported as
Charles Darwin’s arguments, the book
is a precursor to evolutionary theory.
While Darwin never acquired the
family passion for medicine, he did
inherit his grandfather’s curiosity about
the natural world. During the years
he studied at Cambridge to become
a clergyman, Charles Darwin’s true
enthusiasms were collecting insects
and attending geology lectures. Not
surprisingly, a professor recommended
him for the post of naturalist aboard
the hms Beagle. The post was unpaid
and designed not so much to serve
science as to provide the captain with
the company of a fellow gentleman on
the long voyage. Journals and plates
from the voyage were included in the
exhibit. The plates—which contained

med i c a l h i s t o r i c a l l ib r a r y / t er r y d a g r a d i
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new knowledge about plants, animals,
native peoples, and geology—cemented
Darwin’s scientific reputation.
Darwin would wait more than 20
years to publish The Origin of Species.
He wanted first to increase his own
knowledge and come up with a coherent
theory. He may also have been reluctant—he knew his findings would put
him at odds with both the religious and
scientific establishments. Stress over his
concerns, some biographers speculate,
may have caused Darwin’s chronic headaches and cramps. He found relief in the
“water cure” many Victorians took for all
manner of complaints. A text on the cure
was among the items on display.
Darwin was finally pushed toward
publication when he learned that the
naturalist and explorer Alfred Russell
Wallace had developed a strikingly similar thesis. Friends of Darwin arranged

for the joint publication of the Wallace
and Darwin papers, and Origin followed.
Within two decades, most of the scientific community accepted Darwin’s
theory of evolution, though debate
about natural selection stretched on
for decades.
Darwin’s landmark contribution to
science—and the ongoing controversy
it stirs in some circles—made the
anniversary year a major public event.
At Yale, it was observed throughout
the campus. This spring and summer,
the Peabody Museum took passengers
aboard a wooden schooner to simulate
the conditions on the hms Beagle.
Colleen Shaddox is a freelance writer in
Hamden, Conn.

o p p o s i t e , l e f t Charles Darwin in a portrait by John Collier from 1881. The year 2009
marked the 200th anniversary of his birth and
the 150th anniversary of the publication of his
landmark The Origin of Species.
o p p o s i t e , r i g h t On Santa Cruz in the
Galapagos Islands, a crab climbs over volcanic
rock to escape the pounding waves. Darwin’s
observations of the differences in flora and
fauna in the islands of the Galapagos archipelago led him think about how life evolved.
a b o v e Among the Medical Historical Library
collection is a first printing of the first edition
of The Origin of Species, published in 1859.
Darwin’s ideas have held up and provide a
unifying theory of evolution.
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Center Director Lars Brandén
became hooked on gene therapy
after reading a science magazine
in his native Sweden. He has done
research at that country’s Karolinska Institute and at Columbia
University.
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Pioneering the West Campus
Lars Brandén and his colleagues at the Center for High Throughput Cell
Biology are the first scientific team to occupy space at West Campus.
Others will follow in the coming years.

By Jenny Blair
Photographs by Robert Lisak
As an 11-year-old in Sweden in 1979, Lars Brandén read about
retroviruses in a popular science magazine, and it occurred to
him that they could introduce healthy genes into cells. “I told my
father I would do gene therapy when I grew up,” he said, laughing. “When you’re 11 years old, you don’t know. But I did.”
Now director of the Yale Center for High Throughput
Cell Biology, Brandén, 41, has kept that promise, and moved
on to another frontier of genetic research, in keeping with his
propensity for exploration and individualism. He wears his hair
long and has been known to sport a handlebar mustache. The
Thor’s Hammer around his neck is a replica from the era of an
ancestor who was a henchman of a 12th-century Norse king.
He smokes cigars and feeds the piranhas in the tank in his
office with meat on a string.
That office is on the West Campus, where Brandén and
his colleague James E. Rothman, ph.d., professor and chair
of cell biology, Wallace Professor of Biomedical Sciences, and
executive director of the center, run the first laboratory to move
into the 1.6-million-square-foot former Bayer facility, which
Yale purchased in 2007. The center is housed in a building
just inside the West Haven town line, a few hundred feet from
the tiny Oyster River. In the lobby is an old-fashioned popcorn
wagon, a coffee table that used to be a packing crate for lab
instruments, and a large photograph of 16 smiling scientists.
Apart from several staff members from the Peabody Museum,
these 16 people are the first Yale researchers to colonize the
West Campus. There, in the first of three core science facilities
planned for the West Campus, they are quietly performing
genetic research on a scale that beggars the imagination.

Starting from scratch

When Brandén and the team arrived at Building B-31 on
the West Campus in July 2008, they started from scratch.
“Not even the toilets were working. … We had to buy pens,
even. We had no phones—nothing,” he says. The rooms
were then gutted and painted, data jacks were installed,
and the researchers began placing orders for the most stateof-the-art equipment available: automated liquid and plate
handling platforms, an Opera confocal imaging system,
a 24-cpu Linux computer cluster, and many other items,
some of them custom-built.
But Brandén is used to being the first man in a new
environment. The Center for High Throughput Cell Biology
is the third such infant facility he has joined. In 1995, he was
one of the first scientists to work at the new southern campus
of the Karolinska Institute, just outside Stockholm. There he
kept his childhood vow by studying gene therapy while earning
his doctorate in cell and molecular biology. Several years later
he helped design and set up Columbia University’s Genome
Center and its high-throughput chemical compound screening
facility, at which he served as associate director until last summer’s move to Yale with Rothman and several other colleagues.
Brandén’s experience in New York made the setup
process faster. Whereas the Columbia institute took some
18 months to get up and running, Yale’s was ready in 13, even
though it is a more complex operation.
Perhaps unsurprisingly for a man who takes pride
in his Viking ancestry and sometimes hunts his own food
with bow and arrow, Brandén relishes the role of pioneer.
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At a new campus, he said, one has “freedom to explore novel
approaches for doing science without having a preconceived
idea as to how it should be done. [It gives] you more freedom
to define what direction you want to go in yourself instead of
having to battle old fiefdoms.”
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First teams to use the core

Daniel DiMaio, m.d., ph.d., vice chair and Waldemar Von
Zedtwitz Professor of Genetics, and his team are among
the first Yale scientists to make use of the center’s services.
Brandén’s group helps researchers learn how cellular processes
unfold by examining the function of every gene in the human
genome more or less at once. In each of thousands of tiny
adjacent wells, a different gene is deactivated to determine how
cells react. Laser microscopes scan the wells and send data to
computers with between 10 and 80 terabytes of disc space. The
final result is an inventory of genes that may be important to
the cellular process being studied as well as information about
the pathways those genes may affect, loaded on a jump drive
that fits on a researcher’s key ring.
DiMaio and graduate student Alex Lipovsky study the
human papilloma virus (hpv), 13 of whose 130 types can cause
genital warts and cervical cancer. The researchers are interested in the crucial first steps of infection: how the virus enters
human cells and expresses its genes. All hpv types consist of a
protein shell around a length of dna that encodes between six
and eight genes. Human cells and the virus’ protein coat interact in such a way that the cells allow the virus to enter. The center is working with DiMaio’s team to design an assay to pinpoint
the cellular genes involved in this event. Lipovsky began by creating a pseudovirus whose protein coat is identical to hpv’s but
whose innards contain only a gene encoding a green fluorescent
protein. This stand-in for the real virus is later mixed with cells
in which one gene has been selectively deactivated.
The experiment takes place in tiny volumes and huge
numbers. Within the center’s labs are machines that hold 70
plates, each plate containing 384 wells a few millimeters in
diameter and holding 50 microliters each. Robots inject 1,000
human cells into each well. Then “bullets” that knock out specific genes are introduced: small interfering ribonucleic acids, or
sirnas. These short lengths of rna, discovered 10 years ago in
plants, are now available in synthetic form, several for each gene
in the human genome. The sirnas effectively disable the gene
in question—a different gene in each well—and are available to

researchers in vast libraries. The sirnas are mixed with the cancer cells for 48 hours; then the pseudovirus is introduced.
Cells that take up the pseudovirus glow green. Some
cells take it up less effectively than others, and some never take
it up at all. A cell that doesn’t glow either did not take up the
virus, prevented viral transit to the nucleus, or failed to express
the green fluorescent protein or express the virus—and that
is important, since it may mean the specific gene silenced in
that well by that sirna is critical to virus uptake or gene expression. Those variations in the brightness of the green glow—the
range of fluorescence—are examined, quantified, and sorted
out by the automated microscope and software, leading to hits
that may be crucial genes in the process of hpv infection.
DiMaio’s group of researchers will then go on to study the
candidate genes in their own lab.
Though suppressing genes to see how that alters cell
behavior sounds straightforward, Lipovsky said that “the devil
is always in the details.” There are countless technical steps
that must be refined to perfection before the assay can be run,
and it takes months of planning to hash them out. How long
and at what temperature should the cells be incubated? How
should the growth medium’s greater viscosity at the edges
of the plates be accounted for? Many commercially available
sirnas have never been tested—will they do their job and
knock out the genes? The center takes pride in its ability to
guide researchers through these complex questions of experimental design. For several months Lipovsky spent several
days a week driving to West Campus and meeting with assaydevelopment specialist Michael Wyler, m.a., also formerly of
Columbia, to discuss these details.
This kind of collaboration with clients, Brandén says,
sets the Yale center—which charges both Yale investigators and
outside parties a fee for service to cover some of its costs—apart
from many of its competitors. At another university that offers
high-throughput sirna screening, he said, “referring investigators have to come and do the screens themselves. So you have
access to instrumentations, and access to the facilities, but basically, you’re also inviting everyone to do the same mistake over
and over again. ... We have a different approach, we’re taking the
investigator here, we work with him to help him develop their
assay, then we run it for him.” Wyler added that the approach at
Yale is both fun and science-oriented. “We actually interact with
the PIs, sit down, have science conversations, plan out the assays
correctly, and work with them from the beginning to the end.”
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In his lab at West Campus, Lars
Brandén (right) looked over results
with Leena Kuruvilla, Susanne
Hasse, and Michael Wyler.

“You can definitely feel the enthusiasm. With this
screen, we’re getting an integrated picture of how [hpv] infects
the cell,” said Lipovsky. “And this has never been done before.”
A revolution in high-throughput screening

High-throughput screening (hts) technology, which can also
employ chemical compounds rather than sirnas to knock
out genes, was developed in the late 1980s and has since
been a mainstay of drug discovery within the pharmaceutical
industry. Only in the last 10 years has the technique moved
to academia on an industrial scale. Yale is joining the wave of
academic institutions to institute hts capacity; other pioneering groups include the Broad Institute of the Massachusetts
Institute of Technology and Harvard, and Stanford’s HighThroughput Bioscience Center.
Relying as it does on complex and costly robots, laser
microscopes, and vast computing power, hts might be thought
of as research on a scale appropriate to the spectacularly complicated workings of the cell. A cell’s machinery comprises
a series of chemical signals that, like a microscopic Rube
Goldberg contraption, each set off a different process that cascades toward an end result. Unlike a Rube Goldberg gadget,
though, these signals proceed across intricate networks rather
than linearly.
Teasing out how each gene product interacts with the
next one has historically taken years; to date researchers have
pieced together only small parts of human cell networks. Most
previous methods relied on chemical compounds alone to
knock out one part of a cellular process. But the chemicals can
deactivate more than just the process in question, complicating
the analysis. “All drugs like that are dirty ... which made it very
cumbersome to delineate,” said Brandén. The tidy specificity
of sirnas—their ability to deactivate a single gene—is part
of what has allowed the hts revolution to take place. Also,
advances in automation and computing now allow thousands
of experiments to occur within a day. The rich lodes of data
from an hts assay can be examined by advanced software for
hits, or promising results. Many of the hits lead nowhere, but
a few will point the way to genes or other compounds that are
important to the process being studied. Gradually, a network
of intracellular interactions becomes clear and can be mapped
out graphically on powerful computing platforms. And once
those networks are understood, scientists can begin to design
drugs for tweaking them.

The frontiers so far seem limitless. Once one cell type’s
networks are understood, the researchers can explore those of
related cell types to pinpoint important differences. Genetic
variations will lend yet another dimension to the hunt. “If you
understand the differences,” said Brandén, “then you can also
understand the side effects of drugs, how diseases are progressing in different tissues, and why they behave as they do.”
With dozens of cpus crunching the data—and the center is able to tap up to 1,000 more at Yale’s High Performance
Computing cluster in downtown New Haven—the sheer scale
of the work is breathtaking. But the size of the human genome
makes it necessary. After a half-century of research, only about
one-tenth of the human genome’s function is understood.
Some 20,000 to 25,000 genes are thought to exist, but how
they and their protein products interact is still largely a mystery. High-throughput screening speeds up discovery by orders
of magnitude. Currently, the center has the instruments to run
experiments on 200,000 wells per day, but that level of production would need a team many times the size of the present.
As part of the center’s long-term plans, Brandén expects
to design several hundred such cell-based assays that will allow
an exploration of the entire human proteome. “If you cover
the whole proteome, you can then get supremely detailed
information about any unknown gene. You can profile drugs
to understand what they would do on a global level.” This
approach would vastly reduce the number of animal subjects
needed in trials, he said. “You can actually understand what’s
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The scientists and staff of the Yale
Center for High Throughput Cell
Biology come from a variety of
backgrounds. Center director Lars
Brandén is from Sweden and his
team includes a former firefighter
from Arkansas, a computer scientist
from the Ivory Coast, and an
informatics director who raises
carnivorous plants.
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Back row, from left: Steve Berman,
Phil Williams, Marie-Aude Guié,
Laurie Tomei, Lori Ortoleva-Donnelly,
Lars Brandén. Front row, seated;
Leena Kuruvilla, Yan Song, Adrian
Poffenberger, and Susanne Hasse.
Seated on ground: Michael Wyler
and Jason Ignatius. Not pictured:
James Rothman, Deborah Smith,
Trisha D’Errico, and Michael Richo.
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happening before you go there. You can direct the efforts of
medicinal chemistry.”
The center will try to break even and it is run as a business. A small, early investment allowed Brandén to hire a
marketing company and contact cell biology investigators in
academic and industry centers around the world, thus creating
a targeted database of potential customers.
The Center for High Throughput Cell Biology is a
model for two other core research facilities planned for West
Campus. A second facility will provide gene-sequencing services, and will be led by Richard Lifton, m.d., ph.d., chair and
Sterling Professor of Genetics. The third group, which will
perform high-throughput screens of drug-candidate chemical
compounds, will be organized and overseen by Craig Crews,
ph.d., professor of molecular, cellular, and developmental biology. Thanks to the campus’ vast size and resources, the three
cores, expected to be up and running by December, will boast
an information-gathering capacity rare in academia.
And the cores in turn will support departments and
programs across the university, including five new interdisciplinary research institutes: the Institute of Cell Biology, also led
by Rothman; and institutes of chemical biology, cancer biology,
microbial diversity, and systems biology. Like the Center for
High Throughput Cell Biology, these institutes will comprise
groups of researchers from across the sciences, including
engineers, chemists, geologists, and forestry experts as well as
biologists of every stripe. “The strong sense of the science community at Yale and elsewhere is that it is going to be important
to mix up these disciplines a little bit. There will always continue
to be really strong science coming out of the core disciplines, but
the most exciting opportunities might lie at the intersections
[of different disciplines],” said Michael J. Donoghue, ph.d., vice
president for West Campus planning and program development.
“One of the ways that the West Campus can be useful is to break
down those barriers by actually co-locating people from those
different disciplines. It provides an opportunity to do something
you can’t really physically do on the central campus.”
The wild, wild West Campus

In keeping with that wild West Campus culture of diversity,
the center’s team members have a broad spectrum of training,
backgrounds, and interests. (They also hail from several different countries; their potlucks, featuring international cuisine, are
reportedly superlative.) Bioinformatics investigator Phil H.

Williams, ph.d., grew up in Horseshoe Bend, Ark., where he
worked as a volunteer firefighter and helped his father run a
lawnmower-repair business. After his father bought an ibm 386
to keep track of inventory, Williams was hooked, developing a
deep fascination with computers. He eventually left Horseshoe
Bend and studied bioinformatics at the University of Arkansas.
Research informatics scientist Marie-Aude Guié, m.s., is a computer scientist who hails originally from the Côte d’Ivoire. She
puts up with good-natured teasing about being a princess, as
her father is king of their ethnic group, the Baoulé, in her home
country. Ashima Bhan, ph.d., is the team’s cell culture biologist
and has a background in toxicology. Informatics director Adrian
Poffenberger, m.s., who grows carnivorous plants in his office,
has studied biology, mathematics, and cheminformatics, and has
14 years’ experience in drug discovery research.
With researchers of such disparate backgrounds bringing their ideas to the table, “intense brainstorms” are the norm,
and Brandén says team meetings are a lot of fun. “We’ve had
more positive science interactions in the last six months here
than we had over four years at Columbia,” he said. (The transition from New York to suburbia also appears to have gone
relatively smoothly. Brandén has a house in the Woodbridge
countryside where he barbecues on his riverside deck, while
Wyler, formerly a Brooklynite, says he likes being able to drive
to work and park in front of the building.)
The center’s hts assays hold the potential to reveal more
information about cells and in greater detail than has ever been
possible at Yale. hts, said Lipovsky, is itself a marker of a shift
toward greater complexity in science. “If we’re to make the next
leaps in science, we need to understand not only how genes
work by themselves, but also how they work together,” Lipovsky
said. “We need to understand processes, not just genes.” He
is excited not only for the hpv results that will come from his
carefully designed assay, but also to be a part of the center’s
maiden voyage. After all, he said, “the reason I’m in science is
to pioneer things.”
For his part, Brandén says he is in the perfect job. “I’m
dying to know things,” he said. “I’m a very curious kind of person.” With high-throughput screening, “you’re exposed to new
science every single project that you run. And the allure of visualizing and understanding a complete transduction network—
not only one pathway, but the global one—that is intense.”
Jenny Blair, m.d. ’04, is a writer and physician in New Haven.
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Yale’s

Physician
Associate
Program
nears 40

A medical profession that began in the 1960s has
become an essential participant in health care.

By Jennifer Kaylin
Illustrations by Gary Clement

As did the first physician associates,
Gabriel Rocha started his route to
medicine in the military. As a U.S.
Army medic based in Baghdad,
Rocha treated many of those
injured when the United Nations
headquarters were bombed in 2003.
After leaving the army, Rocha came
to Yale for training as a physician
associate. While at Yale, he was
inducted into the U.S. Navy, where
he will serve upon his graduation.

In 2002, a year after graduating from high school in Brigham
City, Utah, Gabriel Rocha enlisted in the U.S. Army. He
decided to become a medic, in large part because the position
included airborne training and he thought the idea of jumping
out of planes sounded adventurous and exciting. But it wasn’t
long before he got to see what a medic’s job is really about.
In 2003, the United Nations headquarters in Baghdad was
bombed; many of the casualties were brought by helicopter to
the aid station where Rocha was deployed.
“People had been dug out of the rubble,” he recalled.
“There were burns, shrapnel injuries, blunt force trauma, and
head injuries.” The number of wounded was so overwhelming
that even the senior medics were treating patients independently, along with the doctors and physician assistants.
Rocha worked closely with the pas—as physician assistants have been known since the mid-1960s, when their profession was born—as well as doctors. “Basically, you couldn’t tell
the difference between them, that’s how knowledgeable and
professional the physician assistants were,” he said. That event,
like so many others, combined with the daily occurrence of
treating Iraqi civilians—including many children—who came
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Alfred Sadler Jr. and his twin brother, Blair, were co-founders of Yale’s
Physician Associate Program in
1971. The young program offered an
opportunity for medical corpsmen
returning from Vietnam to apply
skills learned on the battlefield to
a civilian setting.

Nurse Ann Bliss helped launch
Yale’s Physician Associate program
and also worked to set national
standards for the profession. Yale’s
was one of the first programs to set
a full-fledged curriculum so that
students would leave, Bliss said,
with “clinical skills and acumen.”

to the aid station for care, convinced Rocha that he wanted to
pursue a career as a pa.
“When I joined the military I wasn’t thinking at all about
the health care field, but then I saw how rewarding it was, taking
care of patients and helping people,” Rocha said. “Becoming a pa
just seemed like the most direct and efficient way possible to get
to do what I wanted to do, which was help others.”
Rocha, who is in his second year of Yale’s 28-month
Physician Associate Program, is following a trail blazed almost
40 years ago by a previous generation of former military personnel who used medical experience acquired on the battlefield
as a springboard to a civilian career in health care. (Although
the preferred term is physician assistant, the Yale program uses
the term physician associate.)
A new program fills a gap

The physician assistant profession began at Duke University in
1965; it was originally designed to train assistants who could
relieve the burdens of overworked general practitioners. In the
early 1960s, the Graduate Medical Education National Advisory
Committee had issued a report that identified a shortage of
primary care providers in rural and underserved areas. It was
thought that physician assistants could help fill that gap.
At the same time, the nascent profession quickly provided an opportunity for medical corpsmen returning from
Vietnam to find a civilian application for their battlefield
experience. During the war, about 30,000 men with medical
experience were being discharged each year; of those veterans, 6,000 had extensive medical training.
“These guys saved lives and made tremendous sacrifices,” said Alfred Sadler Jr., m.d., who served with his twin
brother, Blair, as founding co-director of Yale’s pa program,
which began in 1971. “It was a way to show our appreciation
and to help them assimilate into civilian life.”
Sadler said the birth of this new medical profession was
also aided by a national mood of openness toward progressive solutions to social problems. “We encountered no real
obstacles to what we’d set out to do,” Sadler recalled. “The late
’60s and early ’70s was a time of great innovation in health
care in the United States.” Noting the creation of the National
Health Service Corps in 1972 and President Lyndon Johnson’s
Great Society initiative, which had established Medicare and
Medicaid in 1965 and 1966 respectively, Sadler said “there was
a willingness to experiment with new health care models.”
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Yale’s program got its start when Jack Cole, m.d., then
the chair of surgery, received a trauma training grant from
the Commonwealth Fund, a private foundation dedicated to
improving the health care system. Sadler, who, along with
his brother, a lawyer, had written the original 911 emergency
dispatch legislation and created the region’s emergency medical service infrastructure, thought pas would be ideally suited
to emergency medical care. (In 1968 the Sadler brothers also
drafted and helped implement the Uniform Anatomical Gift
Act, which governs organ donations in all 50 states.) As director of Yale’s trauma program within the Department of
Surgery, Sadler convinced Cole to use the grant money to create a pa program—or, as he put it, “the medical school’s first
experiment in non-physician education.”
Almost four decades later, Sadler calls the experiment
“a tremendous success.” The numbers would seem to support
the growing popularity and acceptance of pa programs globally, as well as at Yale. In 1973, Yale graduated five students
who received a certificate in physician associate studies. Since
then, Yale has graduated 895 physician assistants. Nationally,
77,000 pas are practicing in virtually all medical specialties,
including surgery. There are now 145 accredited pa programs
in the United States, with a growing number in foreign countries, including the United Kingdom, Canada, Japan, and many
African countries studying the American pa model with an eye
toward implementing something similar.
Setting the standards

Ann Bliss, r.n., m.s.w., was part of the team that launched
Yale’s pa program and established national guidelines and standards. “When we got started,” she recalls, “not many leading
medical schools had taken this up.”
She said the architects of Yale’s pa program set two basic
rules: “One was to take college graduates.” The second rule was
that “It had to be equal. We didn’t want anyone saying nursing
is for girls; medicine is for boys.” They also set out to create a
program that would produce leaders in the new profession, in
keeping with Yale’s mission as a university.
The founders were determined to create a challenging
course of study with both didactic and clerkship components.
“We were one of the first programs to launch a full-fledged
curriculum,” Bliss said. “We didn’t want our students to graduate without acquiring clinical skills and acumen.”
The other important ingredient for success, Bliss said,
was accepting students who embraced the philosophy of the pa
program. Bliss was responsible for evaluating each applicant’s
psychological readiness. In addition, “I watched their backstage
behavior. For instance, were they rude to the secretaries?” she
said. “We wanted people who would take a more humanist
approach to patient care, who were team players,” and who
would work well with the doctors.
The curriculum established by Bliss and the Sadler
brothers—a nine-month didactic phase followed by 15 months

of clinical rotations resulting in a pa certificate—remained
the same until the late 1990s. In 1995, students approached
Lawrence S. Cohen, m.d., hs ’65, then special advisor to the
dean, requesting that Yale pa graduates receive a master’s degree
instead of a certificate. They argued that by offering a degree,
Yale would be able to compete for the top students and that a
Yale degree would in turn improve the graduates’ job prospects.
Cohen raised the issue with David A. Kessler, m.d., j.d.,
when Kessler took over as medical school dean in 1997. The
new dean appointed a committee led by Walter Kernan, m.d.,
professor of medicine, to review the program. “The pa program
had been a bit under the radar at the institution for a number
of years,” Kernan said. “It was doing a great job of training pas,
but its visibility in the larger academic community of the medical school wasn’t high, because it had never been fully integrated into the training of medical students and residents.”
The committee found that Yale was in the minority in
giving its pa graduates certificates rather than degrees. “But we
decided we didn’t simply want to grant a degree to get the best
students,” Kernan said. “We wanted to grant a degree only if
the curriculum warranted a graduate degree.”
After a thorough analysis of the curriculum, including comparing it to the curricula of the university’s nursing,
medical, and graduate schools, the committee determined that
with certain changes, a Yale pa education would be worthy of
a master’s degree. Their main suggestion was that pa students
should be required to write a thesis like their medical school
counterparts. The program wasn’t long enough for students to
conduct independent research and analyze the results; however,
they could produce a finished product comparable to a biomedical research grant application.
The other recommendation was that the medical school
had to take more ownership of pa training. “At the time we
met, it was common practice for the pa students to get their
training away from campus and away from Yale-New Haven
Hospital at other hospitals and community practices,” Kernan
recalled. “We felt that the faculty of the medical school needed
to be more engaged in the teaching of these students.”
After the committee’s recommendations were implemented, the program grew in length to 25 months to give
students time to write a thesis, and students began doing
their clinical rotations alongside medical students at YaleNew Haven Hospital. In addition, it became a requirement
that pa instructors have a strong affiliation with or a faculty
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Yale’s Physician Associate Program nears 40

appointment in the medical school. Directed by Associate
Dean Mary Warner, m.m.sc., pa-c, the pa program is under
the umbrella of the medical school, with academic oversight
from the deputy dean of education and administrative oversight
from the medical school dean. Starting in 1999, pa graduates
began receiving a full master’s degree.
Kernan says that the move from granting a certificate to
conferring a degree was a necessary next step in the program’s
coming of age. “I heard from some pa students just recently,”
he said. “They said that if Yale were not granting degrees, they
wouldn’t have come here.”
Another milestone for the pa program came in July
2003, when the national Resident Review Committee (rrc)
mandated that resident physicians be held to an 80-hour work
week. “We went into crisis mode,” said Robert Udelsman,
m.d., m.b.a., the William H. Carmalt Professor of Surgery and
Oncology and chair of the Department of Surgery. “If residents
were held to an 80-hour work week, there was no way we could
comply with our then-workload, which has since tripled.”
The solution? More pas. There were two full-time pas
on surgical services before the rrc mandate; now there are
26. “It’s been extraordinarily successful,” Udelsman said.
“It basically solved the crisis.” Beyond that, Udelsman says
the presence of pas to help with floor management of patients
has benefited the physicians as well as patients. “The pas are
here long term, whereas the residents cycle through,” he said.
“The pas have played an incredibly important role in stabilizing
services. They are fully integrated into our patient care model,
and without them we could not function at the level that our
patients and their families deserve.”
The most recent change in the pa program, which went
into effect a year ago, was to extend it from 25 to 28 months.
The three extra months were added to the didactic phase to
enable instructors to cover all the material that is now required.
“We found it increasingly difficult to cover all the mandated
topics,” said pa Program Director Warner, “and we also wanted
to reduce the stress on our students and give them enough
time to participate in the Yale community.”
Assistant v. associate

Yale may have joined the majority of pa programs a decade ago
in offering a master’s degree, but it has remained resolutely
independent when it comes to the name of the Yale program—
for reasons that run deeper than mere tradition. In the early

days, more than half the pa programs nationally were called
physician associate programs, but as time went on, the preferred term became physician assistant, which is the term used
by the American Medical Association (ama).
“It comes up for debate within the profession every five
years or so,” said Warner, “But we feel that assistant sounds
hierarchically lower and that associate is a more accurate reflection of the pa’s role with respect to patients and physicians.
Our program is called physician associate, because that’s what it
was called when it started, and I’m not changing the name; the
alumni would revolt.”
But this debate enters into a deep current that runs
through the profession—one that seeks healthy relationships between men and women, care and cure, colleagues
and subordinates.
From the outset, there were those who questioned the
need for another allied health profession. After all, nurses,
a known quantity to both physicians and patients, had successfully been carrying out many of the same functions for
years. Indeed, as early as 1969, the ama had held discussions
with the American Nurses Association about the possibility of nurses becoming physician assistants. The women’s
liberation movement was starting to resonate with professional women, however, and the nurses emphatically rejected
the proposal for fear that they would become handmaids of
patronizing male physicians. That refusal to broaden the
scope of their practice led directly to the creation of the new
midlevel profession of physician assistant, which was largely
male-dominated in its beginning.
The profession of nurse practitioner was established at
around the same time as the pa program; however, the two
programs have different curricular emphases, according to
Warner. “We emphasize medical sciences in pa training, similar to the medical school model,” she said, “whereas advanced
practice nursing emphasizes integration of the physical and
psychosocial assessment, health promotion, and disease management. Another difference in the two professions is that pas
work with physician supervision while nurse practitioners may
opt for independent practice in many parts of the country. ”
When the pa program got started, the majority of students were military veterans, but as time has passed the profession has become feminized as women have turned to it as a
way to strike a balance between a meaningful career in health
care and family life.
Warner, who became a certified pa in 1992, is one
such woman. She had planned to become a doctor since she
was a child of 10. After college, she worked for two years in
a health care environment to gain some experience and pay
off student loans. It was then that she met her first pa and
became intrigued. She began to weigh the years of medical
training required to become a physician against her desire
to raise children and decided that becoming a pa was the
better route to take.
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“I thought this would be a very efficient way to do a lot
of what I love without having to turn off or postpone the rest
of my life,” she said. Has it been a good decision? “Absolutely.”
The added plus, which Warner didn’t foresee when she started
out, is that unlike medical students, who must choose a specialty, pas train in a generalist model. That means that they can
move from one specialty to another with on-the-job training
from a supervising physician.
After getting her pa degree from Emory University
School of Medicine Physician Assistant Program, Warner
worked in orthopaedic surgery for three years. Then she
switched to cardiac surgery for five years before returning to
orthopaedic surgery. When she came to Yale, she worked in
emergency medicine.
Mathew Simmons, m.m.sc., pa-c ’06, went so far as to
apply to and get accepted by a medical school, Florida State
University College of Medicine, before deciding to become a
pa instead. “The summer before my senior year, I volunteered
in an operating room at a local hospital,” Simmons recalled.
“The whole time I didn’t feel great about medical school.
Then I got engaged and realized I wanted to put my family
and home life first. My stepdad is a doctor, so I know how
much you have to sacrifice.”
Simmons, who works in a gastroenterology practice
in Florida, has no regrets about not going to medical school.
“I still have plenty of responsibility, and I take care of patients
every day,” he said. “It’s very challenging and intellectually
stimulating.” The only downside, Simmons said, is the frequently asked question, ‘Are you going to go on and become a
doctor?’ “I have to tell them, no, that’s not how it works. It’s a
little annoying, but you get used to it.”
According to Warner, about 92 percent of Yale’s pa
students receive some form of financial aid, compared to 83
percent of medical students. “If you look at who we train, our
students have smaller parental contributions with less money,
so time and money are important factors.”
Warner said many people who apply to become pas are
looking for second careers. Thea Cogan-Drew, who enrolled in
Yale’s program in 2007 and will graduate in December, worked
as a photographer, graphic designer, and art director for several
years before she “hit a plateau,” and began looking for a more
satisfying career.
“I explored a lot of career options before coming to
medicine,” she said. “Then, based on where I was in my life

During her tenure as director of the
program, Mary Warner has overseen
an expansion of the program from
25 to 28 months. The additional
three months allow instructors to
cover all the didactic material that
is now required.

personally and professionally (she is the mother of a 4-yearold son and pregnant with her second child), I decided that
the pa degree was the best route for me, as opposed to medical school.”
The National Commission on Certification of Physician
Assistants estimates that pas do 80 to 90 percent of what
physicians do but bill at 15 percent less. As the nation grapples
with ways to overhaul the health care system to make it more
accessible and affordable, many people see an expanded role
for physician assistants as a key part of the solution. “From the
country’s point of view, it’s an incredibly important program,”
said medical school Dean Robert J. Alpern, m.d., Ensign
Professor of Medicine.
“Access to cost-effective care is who we are,” said John
Bond, pa-c ’76, who has worked as a pa in Vermont since his
graduation. “We’re talking about people who are interested in
providing care to patients in underserved areas and training
those people in less time and at a lower cost. What isn’t there to
like about what pas can do in this time of health care crisis?”
Jennifer Kaylin is the Web editor of the ysm Office of Institutional
Planning and Communications.
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notes

David
Hafler

John
Krystal

Stephen
Waxman

MS expert named to
head neurology

Psychiatry professor
named chair

david a. hafler, m.d. , a
leader in multiple sclerosis (MS)
research, was named chair of neurology at the School of Medicine
and chief of neurology at YaleNew Haven Hospital, effective
September 1.
An expert on the mechanisms
of autoimmunity and inflammatory diseases of the central
nervous system, Hafler was director of molecular immunology in
the Department of Neurology
at Harvard Medical School and
an associate member of the
Broad Institute of Harvard and
mit. He was the Jack, Sadie, and
David Breakstone Professor of
Neurology (Neuroscience) at
Harvard Medical School, and
a neurologist at Brigham and
Women’s Hospital.
Hafler’s recruitment complements ongoing research at Yale
in neurology, genetics, and translational immunology. Hafler will
build upon existing neurology
research in such areas as spinal
cord injury and repair, epilepsy,
and neurodegeneration, and he
will expand research in MS and in
other areas of neurology and the
clinical neurosciences.
Hafler succeeds Stephen
G. Waxman, m.d., ph.d. , the
Bridget Marie Flaherty Professor
of Neurology, Neurobiology, and
Pharmacology, who has led the
department since 1986 and will
remain on the faculty and continue as director of the Center for
Neuroscience & Regeneration/
Neurorehabilitation Research.

john h. krystal, m.d. ’84, was

Stephen G. Waxman, m.d., ph.d.,
the Bridget Flaherty Professor
of Neurology, Neurobiology,
and Pharmacology, received the
William S. Middleton Award, the
highest scientific honor bestowed
by the Department of Veterans
Affairs, at the U.S. Capitol in
Washington in April. The award
includes a cash prize of $150,000 in
research support.
Waxman was honored for his
research on spinal cord injury,
multiple sclerosis, and painful
nerve injuries. His research was
the first to show the changes
in molecules within nerve
cells that permit remissions—
recovery of such lost functions
as vision and motor control—in
multiple sclerosis. He has also
identified key molecules responsible for pain after nerve and
spinal cord injury.
Waxman is the director of the
Neuroscience and Regeneration
Research Center, a collaborative
enterprise of Yale University, the
Department of Veterans Affairs,
the Paralyzed Veterans of
America, and the United Spinal
Association. He is also co-director
of the Yale-London Collaboration
on Nervous System Injury at University College London. Having
served as chair of neurology since
1986, Waxman is now making
the transition to a full-time role
as director of the research center
at the VA Connecticut Healthcare
System in West Haven.

named chair of the Department of
Psychiatry, effective July 1. Krystal,
the Robert L. McNeil, Jr., Professor
of Translational Research, will also
serve as chief of psychiatry at YaleNew Haven Hospital. He is director
of the Center for the Translational
Neuroscience of Alcoholism,
and he also heads the Clinical
Neuroscience Division of the
Veterans Affairs National Center
for Post-Traumatic Stress Disorder
and the Veterans Affairs Alcohol
Research Center at Yale. Since
2000, he has served as the department’s deputy chair for research.
Krystal is an internationally
renowned expert on the neurobiology and treatment of schizophrenia, alcoholism, depression, and
ptsd. His work is distinguished
by its emphasis on translational
neuroscience, the effort to combine emerging brain imaging and
molecular genetic technologies
with psychopharmacology to better understand alterations in brain
function associated with psychiatric
disorders. His research on the glutamate system in the brain has led to
new experimental treatments for
several psychiatric disorders.
Krystal succeeds William H.
Sledge, m.d., who led the department as interim chair during
the past year, and Benjamin S.
Bunney, m.d., who served as
chair for two decades until his
retirement in 2008.

Peter
Salovey

Eleven Yale faculty members,
including six from the School of
Medicine, were elected to the
Connecticut Academy of Science
and Engineering in April in recognition of their contributions to
the advancement of science.
Scientists and engineers elected
to the academy must achieve
distinction through original

William
Sessa

Robert
Sherwin

contributions to theoretical or applied science or engineering.
The newly elected members,
who were introduced at the
academy’s annual meeting at the
New England Air Museum in May,
are Michael Donoghue, ph.d., the
G. Evelyn Hutchinson Professor
of Ecology and Evolutionary Biology and vice president for West
Campus Planning and Program
Development; Peter Jones, ph.d.,
the James E. English Professor of
Mathematics and Applied Mathematics; John H. Krystal, m.d. ’84,
the Robert L. McNeil Jr. Professor
of Translational Research; Lynne J.
Regan, ph.d., professor of molecular biophysics and biochemistry
and of chemistry; Peter Salovey,
ph.d., University Provost and the
Chris Argyris Professor of Psychology; William C. Sessa, ph.d., professor of pharmacology; Robert
S. Sherwin, m.d., the C.N.H. Long
Professor of Medicine and director of the Diabetes Endocrinology Research Center; Abraham
Silberschatz, ph.d., chair
and Sidney J. Weinberg Professor
of Computer Science; Joann B.
Sweasy, ph.d., professor of therapeutic radiology and genetics;
William V. Tamborlane, m.d., fw
’77, professor and section chief of
pediatric endocrinology; and Kyle
T. Vanderlick, ph.d., dean of the
Yale School of Engineering and
Applied Science and professor of
chemical engineering.
The Michael J. Fox Foundation
awarded $125,000 in April to
Yale biomedical engineers Mark
Saltzman, ph.d., chair and the
Goizueta Foundation Professor
of Biomedical Engineering in
the School of Engineering and
Applied Science, and Michael
Levene, ph.d., assistant professor of biomedical engineering,
for research on the obstacles to
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William
Tamborlane

Michael
Crair

drug delivery in regions of the
brain affected by Parkinson disease. Saltzman and Levene will
develop new imaging techniques
that observe the movement of
molecules in the brains of living
animals. These techniques will
make it possible to track the way
in which drugs important for the
treatment of Parkinson disease
move to their target areas under
different conditions.
Levene is a pioneer of deep
brain imaging using multiphoton
microscopy in living animals. This
study will expand the technology
to include molecular tracking of
drugs as they traverse the brain.
Saltzman has published
widely on the development of
efficient drug delivery technology, including the recent addition of water-soluble polymers
to chemotherapeutic drugs to
allow deeper and more stable
delivery to various locations in
the brain.
Michael C. Crair, ph.d., was
named the inaugural William
Ziegler III Associate Professor of
Vision Research at the School of
Medicine this spring. Crair studies
the ways in which the eye gets
wired to the brain during fetal development. He uses a broad range
of experimental techniques,
including in vitro and in vivo
electrophysiology and optical imaging, to examine neural-circuit
development and to investigate
the cellular and molecular mechanisms for sensory map development. Research from his lab will
help advance understanding of
the ways in which a combination
of genetic instruction and sensory
experiences can lead to developmental disorders related to vision.
Pietro De Camilli, m.d., fw ’79,
the Eugene Higgins Professor

Pietro
De Camilli

Thomas
Gill

of Cell Biology, has received a
$100,000 Distinguished Investigator Award from narsad, the
leading charity advancing treatment of mental health disorders.
The one-year grant will help support his research into the role metabolism plays in the regulation
of brain function and its impact
on autism, bipolar disorders, and
schizophrenia. De Camilli is one of
16 scientists honored by narsad
this year.
Thomas M. Gill, m.d., fw ’94,
a leading authority on the
epidemiology and prevention
of disability among older persons, was named the Humana
Foundation Professor of Geriatric
Medicine this spring. Gill is codirector of the Yale Program on
Aging and of the Claude D. Pepper
Older Americans Independence
Center. His research is focused on
understanding the mechanisms
underlying the development of
functional decline and disability
among community-living older
persons and on developing preventive strategies to forestall the
onset and progression of disability among frail at-risk elders. His
other research interests include
the epidemiology and prevention of bathing disability and the
epidemiology of frailty among
older adults.
Jeffrey R. Gruen, m.d., hs ’83,
associate professor of pediatrics and genetics, has received
a $5.2 million grant from the
Manton Foundation in New York
City to further his research on
the genetics of dyslexia. Gruen’s
discovery of a gene involved in
dyslexia was named one of the
top 10 scientific breakthroughs
of 2005 by the journal Science.
Gruen will use the grant monies
to launch a new study that will

Jeffrey
Gruen

Susan
Kaech

compare the complete genomes
of 1,000 dyslexic children with
those of 1,000 fluent readers
to obtain a fine-grained view of
genes known to play a role in
reading disabilities, and possibly
to identify new genes that increase
the risk of developing dyslexia.
Susan Kaech, ph.d., assistant
professor of immunobiology, is
one of 50 researchers named Early
Career Scientists by the Howard
Hughes Medical Institute (hhmi).
This award was created by the
hhmi to fuel the creative energy
of young scientists strained by
reductions in federal funding in
scientific research and education.
The award includes a research
grant of $1.5 million over six years
to support Kaech’s research.
Kaech is an expert on protective
T-cells generated by the immune
system to combat infections.
In particular, she is focusing on
memory T-cells, which are longlived cells that remember pathogens from prior infections and
can provide long-term protection against reinfection. Kaech
is working on ways to enhance
responses to infection and to
improve vaccines.
Shirleen Roeder, ph.d., professor of molecular, cellular, and
developmental biology, the
Eugene Higgins Professor of
Genetics, and a Howard Hughes
Medical Institute investigator,
has been named to the National
Academy of Sciences. Roeder is at
the forefront of scientific research
in molecular genetics; she was
part of a Yale team that fully
characterized the function of the
yeast gene. Roeder specializes in
meiotic chromosome behavior
and cell cycle checkpoints. In
the laboratory, she is studying
a special type of cell division

Shirleen
Roeder

Michael
Sernyak

called meiosis, which is necessary for sexual reproduction, by
isolating and characterizing yeast
mutants with defective meiotic
processes. She has written nearly
100 scientific articles that have
appeared in such journals as Cell,
Science, Genetics, and Molecular
Cell Biology.
Michael Sernyak, m.d., hs ’87,
professor of psychiatry, was
appointed director of the Connecticut Mental Health Center
(cmhc), effective July 1. Sernyak
was nominated by Yale University
and appointed by Thomas Kirk,
ph.d., the commissioner of the
Connecticut Department of Mental Health and Addiction Services.
Sernyak, who replaces the retiring
Selby Jacobs, m.d., served as unit
chief of the Psychosis Studies
Unit at cmhc for five years. In
1996 he joined the staff at the VA
Connecticut Healthcare System
in West Haven and in 2001 was
appointed chief of the psychiatry
service. Sernyak is a nationally recognized health services
researcher who specializes in
treatment issues of the severely
mentally ill. His most recent
areas of focus have been the
development of such metabolic
abnormalities as diabetes and
the delivery of medical care in
patients with schizophrenia.
send facult y news to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to claire.bessinger@yale.edu
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students

A day to reflect on
becoming a doctor

john curtis (3)

The Class of 2009 enters medicine at a
time of change and an ongoing debate
over health care.

yale medicine autumn 2009

t o p Lawrence Cohen and bagpiper Glenn
Pryor led the procession to Commencement
ceremonies at Amistad Park.
a b o v e Fabienne Meier-Abt, Sarah Milgrom,
Kathleen Samuels, Aviva Romm, and Titilope
Oduyebo waited at Cross Campus for the
procession to Old Campus for the university
Commencement.
r i g h t Sheela Smith-Rohrberg Maru and Duncan
Smith-Rohrberg Maru bottle-fed their infant
sons as they waited to receive their diplomas.

For the 96 members of the Class of
2009, Commencement was a day
of sunshine and serious reflection
on the nature and responsibilities of
being a doctor.
Commencement speaker David
Blumenthal, m.d., national coordinator for health information technology
at the U.S. Department of Health
and Human Services, exhorted the

graduates to engage in the debate on
health care reform. “We are witnessing a crisis in the system of care, upon
which we all rely as patients and without which you, and all the classes that
follow you, cannot effectively apply your
art and skills,” Blumenthal said. He
spoke of the rising cost of health care
in the United States, and he framed the
current economic and political climate
as an ideal moment for change as more
people lose employment-based health
insurance. “Timing is everything, and
we are now seeing a combination of circumstances that is rare in the history of
our country and of health reform.”
Blumenthal drew parallels between
the Obama administration and that
of President Lyndon Johnson, which
enacted Medicare and Medicaid. Then as
now, he said, three forces converged—a
crisis in health care, a bipartisan desire to
effect change, and presidential leadership
on the issue. No true health care reform
can take place, Blumenthal said, without
the support of the nation’s young physicians, and he encouraged the graduates
to stay involved in reform efforts throughout their careers. “It can make you a better physician, and it can certainly make
the lives of your patients better.”
In his invocation at the ceremony
in Amistad Park, Jason Frangos,
m.d. ’09, described the process of
moving through medical studies into
the heart of doctoring. “We may look
back to when we first arrived, when
we first received our portions of unrefined ore,” he said. “We smelted and
forged and hammered into iron in the
blast heat of hard work, studying and
memorizing, dissecting and discovering, listening and loving. … We hammered, tempered, and wrought into a
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Commencement awards

This year’s Bohmfalk Prizes for excellence in teaching went to Michael L.
Schwartz, ph.d., associate professor of
neurobiology, for basic science; and to
Frederick D. Haeseler, m.d., associate
clinical professor of internal medicine
and director of primary care clerkships,
for clinical science.
Grace Y. Jenq, m.d., assistant professor of medicine (geriatrics), received
the Leonard Tow Humanism in Medicine Award. The Leah M. Lowenstein
Award went to Laura R. Ment, m.d.,
associate dean for admissions and
financial aid and professor of pediatrics and neurology.
The Alvan R. Feinstein Award went
to Robert M. Rohrbaugh, m.d., associate
professor of psychiatry. Karen J. Jubanyik,
m.d., assistant professor of surgery (emergency medicine), received the Francis
Gilman Blake Award. The Betsy Winters
House Staff Award went to Joshua
Silverstein, m.d.
The Class of 2009 donated its
class gift to the Mila Rainof Memorial
Fund, to help those “who choose the
same path we have chosen,” according
to the class presidents.
—Ayelet Amittay

Online Extra
A complete Commencement
photo gallery can be found at
yalemedicine.yale.edu.

Online Extra
Visit the Online Extra section of Yale Medicine’s
website at yalemedicine.yale.edu to access
more photographs and full coverage of student events, including Match Day and Student
Research Day.

john curtis (3)

tiny spinning needle … a compass that
is our heart.”

t o p l e f t In March, Heather Wachtel celebrated her match to a general surgery residency at
the Hospital of the University of Pennsylvania.
t o p r i g h t Medical student Aimee Two
explained her neurobiology poster at Student
Research Day in June. She was one of 70
students who presented posters on research
in laboratory science, clinical findings, medical
humanities, and international health.
a b o v e Ongoing renovations caused Student
Research Day to move from its traditional home
in the Jane Ellen Hope Building to The Anlyan
Center this year.
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alumni faces

A Navajo doctor tends
to the spirit and body

Patricia Nez Henderson integrates a
concept of balance and harmony into
her thinking about medicine.

r o d ger s l o t t
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When Patricia Nez Henderson, m.p.h. ’94,
m.d. ’00, was a child in rural Arizona,
her grandfather would come to her house
early in the morning and splash water
on her and her siblings. “Get up! Get up!
Go run and meet the rising sun,” he told
them in Navajo. “If you sleep too much,
you’re going to be left behind, and the
morning gods are ready to bless you.”
The children would jump out of bed and
run toward the glow in the east.
From growing up in a Navajo-speaking
community without electricity or running water to completing medical
school as Yale’s first female American
Indian graduate, Nez Henderson’s was
a remarkable journey. Her interest in
medicine began early, influenced by her

Patricia Nez Henderson, the first female
American Indian graduate of the Yale School of
Medicine, combines science and the spiritual
in her practice of medicine.

grandfather—a medicine man—and
other traditional healers in her family.
Most of her relatives worked as shepherds, and she recalls listening to lambs’
hearts with a stethoscope her mother
had bought her. “I’d come home smelling like manure,” she said. “My mother
says that’s when she first realized I’d go
into medicine.”
Nez Henderson earned her m.p.h.
at the School of Public Health in 1994
after earning a degree in biochemistry
at the University of Arizona. Then it was
on to medical school.
It was there that culture shock took
hold. Having grown up among healers
who took patients’ spiritual as well
as physical health into account, Nez
Henderson felt miserable at an allopathic
school. “My heart was dissected from
my head,” she said. “I felt it immediately
upon getting into med school, and there
were no other Native students there,
so it was hard to explain to students or
even my professors what I was going
through.” One day a faculty member
made a thoughtless comment about her
imperfect command of English. It devastated her. At that moment, she said,
she understood why so many American
Indian students leave school. “All I saw
was a room full of men in white jackets,
predominantly white, and I just began to
cry, [thinking] ‘I don’t belong here.’ ”
Shortly afterward, Peterson Zah, a
former president of the Navajo Nation,
came to speak at Yale. Before his speech,
Nez Henderson met with him privately
and told him what had happened. Later,
as he addressed the crowd, he turned
directly to her and spoke words of encouragement in Navajo, whereupon she
decided to stay at Yale.
After earning her m.d., along with
an award in her name given to recognize a graduate committed to improving health among American Indians,
Nez Henderson went to Colorado. Her
sense that allopathic medicine is insufficient—as well as the frustration
among physicians she had witnessed
during clinical rotations at underfunded
Indian Health Service sites—had

convinced her to pursue public health
research. She joined the faculty of the
University of Colorado Health Sciences
Center’s Native Elder Research Center
for a two-year program that trains Native
health professionals for research careers.
Funded by grants from the National
Institutes of Health, the Centers for
Disease Control and Prevention, and the
Robert Wood Johnson Foundation, she
began to study tobacco control and prevention among American Indians, an
interest that continues today.
Tobacco has long been sacred to
Native communities, but its abuse leads
to disproportionately severe health consequences for them. Nez Henderson
studies American Indians’ reactions
to nicotine, which may have genetic
underpinnings. She has also designed
Web-based interventions and smoking
cessation classes that incorporate tribal
practices like prayers, visits to sweat
lodges, and fasting, and that emphasize
the sacredness of life. “Navajo tribes use
a word, hozho, which means ‘in balance’
or ‘it’s beautiful.’ There’s that harmony,”
she said. “Anything that impacts hozho
and makes it go out of balance, we know
that’s toxic, like cigarettes. … It’s a more
holistic approach. Instead of just telling a person to do these things that are
backed by evidence, you combine it with
things that are spiritual.”
Nez Henderson lives in South Dakota
with her husband Jeffrey A. Henderson,
m.p.h., m.d., an internist who is Lakota
Sioux, and their daughter, Zahlanii, 7,
and son, Mato, 5. They head the Black
Hills Center for American Indian Health
in Rapid City. In addition to her research,
Nez Henderson works with tribal leaders
to effect tobacco policy changes within
the Indian nations. “With sovereignty
comes responsibility,” she said. “A lot of
tribes are looking at ways to bring economic development into their communities, but if they put health first, all that
they’re looking for will come next.
“I work all the way from prevention
to cessation to policy,” she said. “I absolutely love what I do.”
—Jenny Blair

At 86, head and neck surgeon
still contributes to medicine and
hospice cause he helped found
One medical school memory that Donald
P. Shedd, m.d. ’46, hs ’53, holds dear
is of the day he walked into the “croup
room” at Grace-New Haven Community
Hospital and peered through the mist
that was then used to treat children with
the characteristic barking cough. There
he caught his first glimpse of his future
wife, a Yale nursing student named
Charlotte Newsom. “You can imagine
how glamorous a woman looks in a
steam room,” he said. She turned out
to be lovely, a gifted pianist who played
Chopin beautifully. They married and
launched two brilliant careers.
Shedd, now 86, ended up joining the
Yale faculty, later became chief of head
and neck surgery at the Roswell Park
Cancer Institute in Buffalo, New York,

and serving as national president of the
Society of Head and Neck Surgeons,
which became the American Head
and Neck Society in 1998. Charlotte
Newsom Shedd, m.n., r.n. ’46, who
passed away two years ago at the age of
84, co-founded Hospice Buffalo, often
working from the dining room table
while caring for her aging mother and
the youngest of the four Shedd children.
She traveled around the country as an
early pioneer of the hospice movement
at the national level.
Both Shedds had high levels of energy.
Now professor emeritus at suny Buffalo,
Shedd still attends weekly tumor board
meetings. He also maintains a database
of head and neck operations at the
cancer institute, where he was chief of
head and neck surgery for 29 years.
In 2007, the department published his
fifth book, a history of head and neck
surgery at Roswell. Shedd is also the
author of Historical Landmarks in Head
and Neck Cancer Surgery and The Early
History of Hospice Buffalo.
“You become conscious of a decrease
in energy in your mid-80s,” said the
surgeon, who gave up windsurfing on
Lake Erie around age 75. But he still
plays tennis and maintains a regular
exercise schedule. He has helped build

n a n c y pa r i s i
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Donald Shedd, a head and neck surgeon in
Buffalo, N.Y., was an early supporter of the
hospice movement in this country, as was his
wife, Charlotte.

houses for Habitat for Humanity and
is an active member of the Unitarian
Universalist Church of Buffalo, where
he moderates a discussion group, serves
on committees, and participates in a
monthly book club.
Shedd earned his bachelor’s degree
at Yale and began his study of medicine in an accelerated program during

alumni tour smilow cancer hospital
During this year’s reunion, about a dozen alumni
toured Smilow Cancer Hospital, which is scheduled to open in October. From the ground floor,
the group took elevators to the upper floors
for views of still-unfinished offices and suites,
with grand views of New Haven. The tour also
took in new operating rooms—where all cancer
surgery at Yale-New Haven Hospital will take
place—and infusion suites. The 14-story facility
will contain nearly 500,000 square feet and will
include 112 inpatient beds, outpatient treatment
rooms, expanded operating rooms, infusion
suites, diagnostic imaging services, and floors
for diagnostic and therapeutic radiology.

j o hn c u r t i s

Online Extra
Visit the Online Extra section of Yale
Medicine’s website at yalemedicine.yale.edu
to access more photographs and full coverage
of this year’s reunion events.
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World War II, when faculty members
were leaving to serve in the military
and medical students were hired to
deliver emergency anesthesia at night.
During his 14 years on the Yale faculty,
he became increasingly interested in the
care of head and neck cancer patients.
He moved to Roswell Park in 1967. “The
job offer in Buffalo was an excellent
one,” Shedd said. “It was one of the best
positions in the field in the country.”
Shedd describes himself as “a modest contributor” to head and neck surgery during what he calls “a fascinating
period” of advances in medicine. “I’d say
there have been modest gains in head
and neck cancer survival and major
gains in quality of life, both cosmetically
and functionally,” he said. “One of my
contributions to care at Roswell Park
was the incorporation of the use of the
surgical microscope in endoscopic diagnosis. It made diagnosis more precise,”
he said. As a faculty member at Yale, he
conducted radiographic studies of swallowing in inpatients after head and neck
surgery. “I did some work at Roswell in
surgical approaches to speech rehabilitation after laryngectomy,” he said.
In addition to his clinical work and
research, Shedd helped train fellows
and residents who began their careers at
Roswell Park. He was involved in medical service in Peru and Nicaragua, as well
as short surveys of oral cancer research in
India, Pakistan, and Ceylon (now called
Sri Lanka). He also held a visiting professorship in South Africa.
While his own career was demanding
enough, Shedd shared his wife’s passion for hospice care. The contemporary
American hospice movement began in
New Haven when the Shedds and others
attended a talk at Yale by Dame Cicely

Saunders, the Englishwoman regarded as
the founder of the modern hospice movement. “We kept talking about it after
we came to Buffalo. We realized there
was a need for such a facility here, so
we formed a founding committee, then
Charlotte took the initiative,” he said. The
couple also collaborated on a survey of
the final period of life in 60 head and
neck cancer patients. Charlotte received
a distinguished alumna award from the
School of Nursing in 1992.
Shedd said the support he and his
wife provided each other throughout
their careers and retirement was crucial.
He considers it a privilege to have been
able to care for Charlotte at home during
her encounter with Alzheimer disease.
She spent her final day in the hospice
inpatient unit she had helped to establish.
“Joseph Campbell said something
about following your bliss,” Shedd said,
referring to the scholar who wrote
about the power of mythology to explain
human experience. “I think I have been
able to do that.”
—Kathy Katella

Familiar Faces

Do you have a colleague who is making
a difference in medicine or has followed
an unusual path since leaving Yale? We’d
like to hear about alumni of the School of
Medicine, Physician Associate Program,
and the medical school’s doctoral, fellowship, and residency programs. Drop us a
line at ymm@yale.edu or write to Faces,
Yale Medicine, 300 George Street, Suite
773, New Haven, CT 06511.
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Richard Lamb

1940s
Aaron T. Beck, m.d. ’46, received
the 2009 Award for Extraordinary Accomplishment in Medical
Research from the Robert J. and
Claire Pasarow Foundation in May.
The $50,000 award is one of three
given each year for basic or clinical
research in cancer, cardiovascular
disease, and neuropsychiatry. Beck,
the University Professor Emeritus
of Psychiatry at the University of
Pennsylvania School of Medicine,
is a member of the Institute of
Medicine and the National Academy of Sciences.

1950s
Richard Lamb, m.d. ’54, received
the 2009 Distinguished Service
Award from the American Psychiatric Association. The award honors
individuals and organizations that
have contributed meritorious
service to American psychiatry.

Anthony Proto

Eduardo
Alfonso

is a professor of radiology at Virginia Commonwealth University
Medical Center.

1980s
Eduardo C. Alfonso, m.d. ’80, the
Edward W.D. Norton Professor of
Ophthalmology, was named chair
of Bascom Palmer Eye Institute,
the Department of Ophthalmology of the University of Miami
Miller School of Medicine, in June.
A 1984 graduate of the institute’s
residency program, Alfonso has
been on the faculty since 1986. He
is known for his clinical expertise
in diseases and surgery of the
cornea and in ocular microbiology
and laser vision correction.

1990s
Matthew B. Klein, m.d. ’97, has
been named the David and Nancy
Auth-Washington Research
Foundation Endowed Chair for

Jiyon Lee

Gualberto
Ruaño

Restorative Burn Surgery at the
University of Washington. Klein
is associate professor of plastic
surgery, associate director of the
University of Washington Burn
Center, and director of the plastic
surgery residency program.
Jiyon Lee, m.d. ’96, assistant professor of radiology (breast imaging) at New York University (nyu)
School of Medicine, was honored
at the American Cancer Society’s
(acs) Diamond Luncheon in May
for her volunteer work with the
acs in Westchester County, N.Y.
Lee has been serving as medical
director and a member of the
board of advisors for the past five
years. She is a mammographer
at the nyu Clinical Cancer Center
and at Bellevue Hospital Center
in New York City.
Gualberto Ruaño, ph.d. ’92,
m.d. ’97, was inducted into the
American Institute for Medical

and Biological Engineering’s
College of Fellows in April at a
ceremony in Washington, D.C.,
at the National Academy of
Sciences. Recipients of this
honor are chosen for exceptional
leadership and achievements in
medical and biological engineering. Ruaño is president and chief
executive officer of Genomas
Inc., a biomedical company based
in Hartford, Conn.; director of
genetics research at Hartford
Hospital; and adjunct professor in the medical faculties of
George Washington University
and the University of Puerto Rico.

send alumni news to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to claire.bessinger@yale.edu
visit us on the web
yalemedicine.yale.edu

1970s

Anthony V. Proto, m.d. ’71, was
awarded the 2008 Gold Medal of
the Radiological Society of North
America (rsna) for his contributions to radiology. The Gold
Medal requires the unanimous
approval of the rsna board of
directors. Proto, who recently
completed more than 10 years as
editor of the journal Radiology,

WA NTE D : I M AG E S O F Y E STE RY E A R

In preparation for the School of Medicine’s Bicentennial in 2010, Yale Medicine is
seeking archival photographs, motion pictures, videos, and sound recordings
depicting the history of the school and its students, faculty, and alumni.
Areas of interest include medical education, student life, medical
practice, and scientific research. Please let us know if you have materials that
could be borrowed or duplicated. All formats are acceptable, including photographic prints, slides, digital files, film and
tape reels, and cassettes. Write to us at
ymm@yale.edu [subject line: Bicentennial
images] or via U.S. mail to Bicentennial
Images, Yale Medicine, 300 George Street,
Suite 773, New Haven, CT 06511. To join the
Bicentennial news and events mailing list,
visit medicine.yale.edu/alumni.

ya l e u ni v er si t y m a nu s c r ip t s & a r c hi v e s

Katherine Benesch, m.d. ’70, j.d.,
a partner in the health law practice group at the Princeton, N.J.,
office of Duane Morris llp, was
appointed to the American Arbitration Association (aaa) Health
Care Advisory Council in March.
The council is a national group
appointed by the aaa to develop
dispute resolution solutions for
the health care industry.
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in memoriam
John R. Brobeck, ph.d., m.d. ’43,
died of pneumonia on March 6
at a retirement community in
Media, Pa. He was 94. Brobeck
served on the Yale faculty
from 1942 until 1952. Brobeck
then chaired the physiology
department at the University of
Pennsylvania School of Medicine
from 1952 until 1973 and for 10
years served as assistant to the
vice president for health affairs.
He was elected to the National
Academy of Sciences in 1975.
Seth D. Charney, m.d. ’69, died
at his home in San Francisco on
March 8. He was 64. Charney
served as a student editor of the
Journal of the History of Medicine
during his years at Yale. He practiced psychiatry in San Francisco,
owned real estate throughout
California, and was a lifetime
champion of human rights causes.
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Edwin L. Child, m.d. ’56, died on
February 14 of brain cancer at his
home in Manchester, N.H. He
was 78. Child was an obstetrician/
gynecologist who delivered thousands of babies during his career
and made medical mission trips
to Liberia, Jamaica, and Kenya.
William F. Collins Jr., m.d. ’47,
the Harvey and Kate Cushing
Professor Emeritus of Neurosurgery and former chair of surgery,
died on June 17 in San Diego. He
was 85. Collins accepted the
position of professor and chief
of neurosurgery at Yale in 1967.
In 1970, he was appointed the
Harvey and Kate Cushing Professor of Surgery. He remained chief
of neurosurgery at the medical
school and neurosurgeon in chief
at Yale-New Haven Hospital until
1984, when he was appointed
chair of the Department of
Surgery. He retired as chair in July
of 1993 and assumed emeritus
status in the Department of
Surgery on July 1, 1994.
Lycurgus M. (Bill) Davey, m.d. ’43,
died on June 15 in New Haven
as a result of injuries from a fall.
He was 91. Davey was a clinical
professor of neurosurgery who
devoted much of his career to

clinical teaching and the training
of Yale neurosurgical residents.
He served as president of the
Association of Yale Alumni in
Medicine from 1995 to 1997. He
read five languages and drew
on his classical education as he
explored and wrote about the
history of medicine, including an article about the Greek
inscription above the entrance to
Sterling Hall of Medicine. He was
an active consultant and clinical
professor in the Department of
Neurosurgery at Yale from 1951
to the present. His recent awards
include the Distinguished Alumni
Service Award in 1997 and the
Peter Parker Medal in 2003
for outstanding service to the
School of Medicine.
William K. Frankenburg, m.d.,
m.s.p.h., fw ’63, an internationally recognized pioneer in child
development and pediatric
preventive medicine, died on
April 3 of acute myeloid leukemia at his home on Bainbridge
Island, Wash. He was 78. In 1967,
Frankenburg and his colleague
at the University of Colorado, Josiah Dodds, ph.d., published the
Denver Developmental Screening Test, known as the Denver II,
which has been used to screen
millions of children around the
world for developmental delays.
Stuart L. Joslin, m.d. ’43, died on
January 25 after a short illness in
North Adams, Mass. He was 93.
Joslin was one of the founding
directors of the Mid-Fairfield
Child Guidance Center and chair
of the Well Baby Clinic, both in
Connecticut, where he practiced
pediatrics until his retirement
in 1991.
Alan D. Lieberson, j.d., m.d. ’62,
died at his home in Westport,
Conn., on February 10. He was 71.
Lieberson used his knowledge of
law and medicine to tackle such
medical questions as euthanasia, living wills, and health
care rationalization. He was a
partner at Internal Medicine of
Westport for 15 years and served
on the medical ethics committee of Norwalk Hospital.

Daniel L. Macken, med ’59, m.d.,
died on March 1 in New York City.
He was 75. Macken served as a
lieutenant colonel in the Army
Medical Corps during the Vietnam War. He was honored by the
United States and the Republic of
South Vietnam for his wartime
medical service. At Columbia
University he founded the Medica
Foundation to support medical
research and activity.
Henry E. Markley, m.d. ’43, died
on February 26 in Greenwich,
Conn. He was 90. Markley
practiced medicine in Greenwich
from 1950 until 1979, and in 1955
launched Greenwich Hospital’s
Home Care Program for the elderly, sick, people with disabilities,
and children with special needs.
Robert W. Ollayos, m.d. ’41, died
on February 23 in a nursing facility near St. Louis of complications
of Alzheimer disease. He was
92. Ollayos, a flight surgeon in
the Army Air Corps during World
War II, conducted research that
contributed to the development
of lifesaving equipment for
babies born with Rh-blood type
incompatibility.
Vincent Pepe, m.d. ’46, hs ’52, an
obstetrician-gynecologist who
delivered more than 10,000
babies during 60 years in private
practice, died on June 20 of congestive heart failure in Meriden,
Conn. He was 87.
Pepe, a native of New Haven,
began his practice in the MeridenWallingford area in 1952. In the
1950s, he helped to forge the use
of prenatal folic acid to prevent
birth defects and later helped
to pioneer work in urological
gynecology. He also helped to
advance surgical treatments for
urinary incontinence for women
as well as laparoscopic operative techniques and ultrasound
procedures in community-based
ob-gyn practice.
Richard C. Petersen, m.d. ’48,
died on February 1 at his home in
Southbury, Conn. He was 85. In
1955 Petersen opened a pediatric
practice in Stratford, Conn., and

became a leader in preventive
pediatric care.
Samuel M. Rice, m.d. ’49, died
on March 3 in Cranberry, Pa. He
was 86. After graduating from
medical school, Rice returned
to the Pittsburgh area and
practiced medicine out of his
house in Cranberry from 1953
until 2003, making house calls
and seeing the same patients
for decades.
Micky Ray Riggs, m.d. ’92, died on
December 26 in Seattle. He was
52. Riggs was remembered for his
insights on topics ranging from
global politics to serial killers to
SpongeBob SquarePants.
Susan S. Spencer, m.d., professor
of neurology and neurosurgery,
died suddenly on May 21 in Salt
Lake City. She was 60. Spencer
was an internationally recognized expert in epilepsy, and
particularly in epilepsy surgery.
She was the co-director of the
Yale Epilepsy Program with her
husband, Dennis D. Spencer, m.d.,
hs ’77, chair of neurosurgery. She
came to Yale as a resident in neurology in 1975, following undergraduate and medical school
education at the University of
Rochester, and joined the faculty
in 1980. She soon wrote major
papers in epilepsy surgery and
published more than 200 original
manuscripts and chapters on
the subject. Her contributions
were recognized by the American
Epilepsy Society Clinical Research
Award in 2003.
send obituary notices to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to claire.bessinger@yale.edu

end note

At this most modern of universities, with its particle accelerators,
radiochemistry facility, and stem cell center, a lone craftsman in a
small workshop helps unravel today’s scientific mysteries using techniques developed centuries ago.
Daryl Smith is Yale’s scientific glass blower. At the Yale Glass
Shop in the Sterling Chemistry Laboratory, Smith helps scientists and
researchers design the equipment they need for their experiments.
“Anything they see in a catalog I can make and customize to fit their
specific needs,” said Smith, who came to Yale in 2005 after working
for private glass companies. He completed his undergraduate degree
in aquaculture from Texas A&M University in College Station and
studied scientific glass technology at Salem Community College in
Carneys Point, N.J. “I like working with my hands,” he said, “but I like
the science part of it, too.”
Smith also teaches a semesterlong course titled “Introduction
to Scientific Glass Blowing,” which focuses on the dexterity needed
to be a glass blower as well as the tools and materials. Last spring, his
six students watched a brief demonstration by Smith before beginning their final project, a Hero’s engine—a device invented by Hero of
Alexandria around A.D. 10 that propels itself by shooting steam from
one or more orifices.
Many research universities outsource their glasswork to private companies, but Smith can meet face to face with researchers
to develop customized products, and he can create or repair a device
the same day if necessary. But perhaps most important, Smith’s loyalty is to Yale, so when he and a researcher develop a new design, he
treats it as proprietary information; he won’t share it as an outside
contractor might.
When Smith isn’t creating or repairing scientific equipment at
Yale, he enjoys the artistic side of glass blowing, creating glass ornaments and gifts at his home studio. Not surprisingly, the Christmas
season is his busiest time. “You’ll find me sitting in front of my bench
torch,” he said, “instead of going to the mall.”
—Jennifer Kaylin

john curtis

A to u ch of g l ass

Glass blower Daryl Smith produces made-toorder glass implements and instruments for
Yale scientists. “I like working with my hands,
but I like the science part of it, too,” he said.

Online Extra
Video of Daryl Smith at work
can be seen at yalemedicine.yale.
edu/glassblower.
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